Back to all news

AI-Driven Whole-Body MRI Biomarkers Aid Myeloma Risk Stratification

AuntMinnieIndustry

AI-powered MRI analysis offers automated risk stratification via body composition in multiple myeloma patients.

Key Details

  • 1A deep-learning system was trained and validated on 39 whole-body MRI scans in multiple myeloma patients.
  • 2The pipeline enables automated tissue and organ segmentation in seconds or minutes, speeding up analysis and reducing operator time.
  • 3Longitudinal MRI analysis revealed that decreases in skeletal muscle and increases in fatty tissue during treatment are statistically significant (p < 0.001).
  • 4Higher baseline subcutaneous adipose tissue predicted better progression-free survival (HR = 0.60–0.67), while increases in visceral fat correlated with worse survival (HR = 2.89).
  • 5Including body composition metrics in routine MRI adds no burden but may facilitate earlier interventions and better patient outcomes.

Why It Matters

This work highlights how AI can transform standard imaging into a biomarker-rich tool that informs prognosis and individualized care in oncology, maximizing existing imaging data without added patient risk or discomfort.

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.